Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-12-02

Clinical Trial Update: RCT Evaluating Effects of Cosmos Caudatus (Ulam Raja) in T2DM Patients [NA]

View source ↗

Summary

A completed randomized controlled trial evaluated Cosmos Caudatus (Ulam Raja) as an intervention for Type 2 Diabetes Mellitus and obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cosmos Caudatus (Ulam Raja)

Snippet

Sponsor: Universiti Putra Malaysia | Conditions: Type 2 Diabetes Mellitus, Obesity | NA | Status: COMPLETED